You just gestured vaguely about it being expensive and "incentives". I would like to know why you believe the private sector is uniquely equipped to "bring drugs to the market" and why you think having middlemen is more efficient than not having them.
No, I simply pointed out that it costs billions to bring a drug to market --- before marketing --- and that you can't plausibly recoup those expenses for a cost-plus priced product. Do you have a response to that? I'm not interested in expanding the argument.
I don't think we need to recoup those expenses. Fund R&D with public money, once a drug is developed and tested it becomes a common good and should pay for itself with the gain of productivity obtained from a healthier population.
You just gestured vaguely about it being expensive and "incentives". I would like to know why you believe the private sector is uniquely equipped to "bring drugs to the market" and why you think having middlemen is more efficient than not having them.
No, I simply pointed out that it costs billions to bring a drug to market --- before marketing --- and that you can't plausibly recoup those expenses for a cost-plus priced product. Do you have a response to that? I'm not interested in expanding the argument.
I don't think we need to recoup those expenses. Fund R&D with public money, once a drug is developed and tested it becomes a common good and should pay for itself with the gain of productivity obtained from a healthier population.
7 replies →